What is ISoP?
The International Society of Pharmacovigilance (ISoP) is an international non-profit scientific organisation, which aims to foster Pharmacovigilance both scientifically and educationally, and enhance all aspects of the safe and proper use of medicines, in all countries. more…
COVID-19 Information
ISoP Seminar
ISoP Boston Seminar 2022
5-6 December 2022
Past Event
Intelligent Automation in Pharmacovigilance
ISoP Symposium
ISoP Mid-Year Symposium
1-2 June 2023 – Leiden, Netherlands
Pharmacovigilance: where science meets clinical practice
In collaboration with Lareb
ISoP 2023
ISoP Annual Conference
6-9 November 2023
Putting Patients First in Pharmacovigilance: International Perspectives from Global South
Patient Safety Day
ISoP 2022
Join ISoP Today
Mira Harrison-Woolrych, past president of ISoP talks about the benefits and fees of becoming a member.
Chapter and SIG Activities
For more information click below.
What’s New
ISoP UK-Ireland (UKIRL) Chapter Elections 2022 results
Sten Olsson Poster Prize: Congratulations to the Egypt Chapter!
Results of the ISoP Advisory Board Elections 2022
The new ISoP Scientific Board (SB) has now been established
Update from the Pharmacovigilance Professional Qualification Framework SIG
Am2P: American Program in Pharmacovigilance
New ISoP Patient Engagement and Medical Device Safety Groups
ISoP infographic ‘COVID-19 Vaccine Safety’
Webinars section for Members
New ISoP membership fees 2022 and Membership Categories
ISoP editorials in Drug Safety journal
CIOMS Establishes Annual Award for Medical Students
ISoP Latest
ISoP
@ISoPonline
💡Remember to participate in the next ISoP #Pharmacovigilance Journal Club on the 30th March at 19.00 UTC.
❕This we… https://t.co/PiiOmQTjw3
Mar 29
ISoP
@ISoPonline
🥰Did you know #ISoPOnline has its own Official Journal?
📣We are pleased to share the Drug Safety Volume 46, Issue… https://t.co/wyvgFrBTNi
Mar 27
Drug Safety
ISoP Official Journal
Drug Safety is the premier international journal covering the disciplines of pharmacovigilance, pharmacoepidemiology, benefit-risk assessment and risk management.
READ MORE